Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?

Oral Oncol. 2014 Jun;50(6):e27-8. doi: 10.1016/j.oraloncology.2014.03.002. Epub 2014 Mar 26.

Authors

Ryan Cotter¹, Seth Blacksburg¹, Todd Carpenter¹, Benjamin Kann¹, Richard Bakst¹, Krzysztof Misiukiewicz², Marshall Posner², Peter Som³, Vishal Gupta⁴

Affiliations

¹ Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY, United States.
² Department of Medicine, Mount Sinai Medical Center, New York, NY, United States.
³ Department of Radiology, Mount Sinai Medical Center, New York, NY, United States.
⁴ Department of Radiation Oncology, Mount Sinai Medical Center, 1184 Fifth Avenue, 1st Floor, New York, NY 10029, United States. Electronic address: vishal.gupta@mountsinai.org.

PMID: 24680084
DOI: 10.1016/j.oraloncology.2014.03.002

No abstract available

Keywords: Head and neck cancer; Induction chemotherapy; Locoregional control; Radiation therapy; Tumor volume.

Publication types

Letter

MeSH terms

Combined Modality Therapy
Dose-Response Relationship, Drug
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / radiotherapy
Humans